Your session is about to expire
← Back to Search
Dietary Sodium (DS) Intervention to Reduce Volume Overload and Tissue Sodium in Magnetic Resonance Imaging (MRI) for Hemodialysis (HD) Patients (DSMRI Trial)
N/A
Waitlist Available
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the impact of dietary salt restriction on tissue sodium levels in HD patients.
Eligible Conditions
- Chronic Kidney Failure
- Dietary Modifications
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Interdialytic weight gain
Tissue sodium
Secondary study objectives
Biochemical markers
Cardiovascular function
Gut microbiome (stool sample)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment2 Interventions
Participants will follow a Observational Control Diet (CON) diet followed by an Controlled Dietary Sodium Restriction (INT) diet.
Find a Location
Who is running the clinical trial?
University of Illinois at Urbana-ChampaignLead Sponsor
199 Previous Clinical Trials
40,445 Total Patients Enrolled
Renal Research InstituteOTHER
34 Previous Clinical Trials
79,394 Total Patients Enrolled